Last updated on November 2019

End-stage Renal Disease (ESRD) Pilot Study


Brief description of study

The purpose of this study is to investigate the safety of two different doses of a drug called BAY1213790 and how well it is tolerated in patients with end-stage renal disease (ESRD) undergoing hemodialysis (HD). Approximately 40, with up to 60 study patients will take part in the study.

Clinical Study Identifier: NCT03787368

Find a site near you

Start Over